Kawa Khaled Ajgeiy
0009-0008-9620-875X
1 paper found
Refreshing results…
Drug Survival of Adalimumab, Secukinumab, and Ustekinumab in Psoriasis as Determined by Either Dose Escalation or Drug Discontinuation during the First 3 Years of Treatment – a Nationwide Cohort Study
Missing publications? Search for publications with a matching author name.